Frequent Links
Mutation Peer-review JournalsInnovations in HistopathologyBayesian-statistics-Open-Access-JournalsLumbar Spinal StenosisBioprotectants Peer Reviewed JournalsPsychosisDowns Syndrome High Impact Factor JournalsExercise PhysiologySiddha Medicinetop bioanalysis online publishing journalsMaterials science Environmental toxicology impact factorLaw-journalsOutbound-Tourism-Scholarly-journal Lymphoma journals list
BHFF
File:BHFF structure.png | |
Systematic (IUPAC) name | |
---|---|
5,7-Bis(1,1-dimethylethyl)-3-hydroxy-3(trifluoromethyl)-2(3H)-benzofuranone | |
Clinical data | |
Identifiers | |
123557-91-5 7px | |
PubChem | CID 4332683 |
ChemSpider | 3537035 7px |
Chemical data | |
Formula | C17H21F3O3 |
330.341 g/mol | |
| |
14px (what is this?) (verify) |
BHFF is a compound used in scientific research which acts as a positive allosteric modulator at the GABAB receptor. It has anxiolytic effects in animal studies, and good oral bioavailability.[1]
References
- ^ Malherbe, P; Masciadri, R; Norcross, RD; Knoflach, F; Kratzeisen, C; Zenner, MT; Kolb, Y; Marcuz, A; Huwyler, J (2008). "Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors". British Journal of Pharmacology 154 (4): 797–811. PMC 2439845. PMID 18536733. doi:10.1038/bjp.2008.135.
Lua error in package.lua at line 80: module 'Module:Buffer' not found.